LATEST NEWS

LJI Professor Sujan Shresta, Ph.D., is a leader in dengue virus research and vaccine development
Shresta and her LJI colleagues work toward pandemic preparedness as members of the national 'ReVAMPP' network
Prebys Foundation celebrates ground-breaking female researchers
San Diego scientists work with business experts to advance dengue and Zika virus vaccine strategy
Sette has led investigations into the T cell response to SARS-CoV-2, tuberculosis, and more
Elong Ngono, Ph.D., accepted to Global Virus Network Rising Star Mentorship Program
LJI scientists uncover major clue toward developing a pan-flavivirus therapy
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.
Future vaccines will need to harness the power of T cells in preventing Zika fever and Japanese encephalitis
The finding is important to both the basic understanding of this disease—the world’s most common mosquito-borne illness—and to the hunt for an effective vaccine for dengue.